Efficacy and safety of azacitidine in pediatric patients with newly diagnosed advanced myelodysplastic syndromes before hematopoietic stem cell transplantation in the AZA‐JMML‐001 trial

Abstract: Here we report efficacy, pharmacokinetics, and safety data obtained in treatment-naive, pediatric patients with newly diagnosed advanced MDS receiving azacitidine in the AZA-JMML-001 study. The primary endpoint was response rate (proportion of patients with complete response [CR], partial response [PR], or marrow CR, sustained for ≥4 weeks). Of the 10 patients enrolled, one had an unconfirmed marrow CR and none had confirmed responses after three cycles; the study was therefore closed after stage 1. Azacitidine was well tolerated. The lack of efficacy of azacitidine in pediatric patients with newly diagnosed advanced MDS highlights the need for effective new treatments in these patients

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
Pediatric blood & cancer. - 71, 5 (2024) , e30931, ISSN: 1545-5017

Ereignis
Veröffentlichung
(wo)
Freiburg
(wer)
Universität
(wann)
2024
Urheber
Locatelli, Franco
Strålin, Karin Belander
Schmid, Irene
Sevilla, Julian
Smith, Owen P.
Heuvel-Eibrink, Marry M. van den
Zecca, Marco
Zwaan, Christian Michel
Gaudy, Allison
Patturajan, Meera
Poon, Jennifer
Simcock, Mathew
Niemeyer, Charlotte

DOI
10.1002/pbc.30931
URN
urn:nbn:de:bsz:25-freidok-2473015
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:59 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.

Beteiligte

  • Locatelli, Franco
  • Strålin, Karin Belander
  • Schmid, Irene
  • Sevilla, Julian
  • Smith, Owen P.
  • Heuvel-Eibrink, Marry M. van den
  • Zecca, Marco
  • Zwaan, Christian Michel
  • Gaudy, Allison
  • Patturajan, Meera
  • Poon, Jennifer
  • Simcock, Mathew
  • Niemeyer, Charlotte
  • Universität

Entstanden

  • 2024

Ähnliche Objekte (12)